Jointechlabs is at the forefront of point-of-care regenerative medicine, specializing in innovative therapies that utilize autologous fat for various medical applications. Their flagship products, the MiniTC® Adipose Processing System and the Mini-Stem System®, are designed to process adipose tissue into microfat and stromal vascular fraction (SVF), respectively. The MiniTC® system is FDA-cleared and operates as a closed-loop, disposable device that efficiently transforms harvested fat into a purified, cell-rich microfat suitable for injection. This technology is particularly beneficial in fields such as orthopedics, sports medicine, aesthetics, and wound healing, offering advantages like reduced pain, improved healing, and minimal risk of complications compared to traditional surgical methods.

The Mini-Stem System®, which has received CE Mark approval for use in Europe, complements the MiniTC® by extracting SVF from adipose tissue, further expanding the therapeutic applications of regenerative medicine. Jointechlabs emphasizes the importance of using autologous biologics, which are derived from the patient's own body, to enhance healing and recovery. Their commitment to advancing regenerative therapies is evident in their ongoing research and development efforts, including pipeline products that explore 3D bioprinting and biologic drugs aimed at treating conditions like osteoarthritis and chronic wounds. With a focus on making these advanced therapies accessible and affordable, Jointechlabs is positioned as a leader in the evolving landscape of regenerative medicine.

United States

Jointechlabs is a regenerative medicine company that offers point-of-care medical devices enabling safe and cost-effective non-surgical treatments.

Jointechlabs

Company Details